Journal
BRITISH JOURNAL OF CANCER
Volume 96, Issue 3, Pages 403-407Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6603547
Keywords
hereditary leiomyomatosis and renal cell cancer; kidney cancer; fumarate hydratase; hypoxia inducible factor
Categories
Funding
- Intramural NIH HHS Funding Source: Medline
Ask authors/readers for more resources
Hereditary leiomyomatosis and renal cell cancer is a recently described hereditary cancer syndrome in which affected individuals are predisposed to the development of leiomyomas of the skin and uterus. In addition, this clinical entity also can result in the development of biologically aggressive kidney cancer. Affected individuals harbour a germline mutation of the fumarate hydratase (FH) gene, which encodes an enzyme that catalyses conversion of fumarate to malate in the Kreb's cycle. Thus far, proposed mechanisms for carcinogeneis associated with this syndrome include aberrant apoptosis, oxidative stress, and pseudohypoxic drive. At this time, the majority of accumulating data support a role for pseudohypoxic drive in tumour development. The link between FH mutation and pseudohypoxic drive may reside in the biochemical alterations resulting from diminished/absent FH activity. These biochemical derangements may interfere with oxygen homeostasis and result in a cellular environment conducive to tumour formation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available